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Abstract
Background: Extracellular signal-regulated kinase 2 (ERK2) is an S/T kinase with more than 200 known substrates,
and with critical roles in regulation of cell growth and differentiation and currently no membrane proteins have
been linked to ERK2 scaffolding.
Methods and results: Here, we identify the human Na+/H+ exchanger 1 (hNHE1) as a membrane scaffold protein
for ERK2 and show direct hNHE1-ERK1/2 interaction in cellular contexts. Using nuclear magnetic resonance (NMR)
spectroscopy and immunofluorescence analysis we demonstrate that ERK2 scaffolding by hNHE1 occurs by one of
three D-domains and by two non-canonical F-sites located in the disordered intracellular tail of hNHE1, mutation of
which reduced cellular hNHE1-ERK1/2 co-localization, as well as reduced cellular ERK1/2 activation. Time-resolved
NMR spectroscopy revealed that ERK2 phosphorylated the disordered tail of hNHE1 at six sites in vitro, in a distinct
temporal order, with the phosphorylation rates at the individual sites being modulated by the docking sites in a
distant dependent manner.
Conclusions: This work characterizes a new type of scaffolding complex, which we term a “shuffle complex”, between
the disordered hNHE1-tail and ERK2, and provides a molecular mechanism for the important ERK2 scaffolding function
of the membrane protein hNHE1, which regulates the phosphorylation of both hNHE1 and ERK2.
Keywords: NHE1, Intrinsically disordered protein, Phosphorylation, MAPK, Shuffle complex, NMR, Scaffold
Background
Extracellular signal-regulated kinase 2 (ERK2) is a mem-
ber of the mitogen-activated protein kinase (MAPK)
family of kinases activated in response to numerous
growth factors and cytokines, leading to phosphorylation
and functional regulation of downstream targets. ERK2
has been linked to more than 200 different substrates
whose phosphorylation by ERK2 is orchestrated by
coordination of signaling networks through common
binding to so-called scaffold proteins [1]. The definition
of a scaffold protein was recently refined and their
identification as such suggested from qualities of multi-
valent binding, non-catalytic placeholders, and bidirec-
tional process control [2]. Several scaffold proteins have
been described for the MAPKs such as kinase suppres-
sor of Ras (KSR) [3], JNK-interacting protein (JIP) [4],
IQ motif containing GTPase activating protein 1
(IQGAP1) [5], and β-arrestin [6], which interact with
members of the MAPK cascade, providing multivalency,
spatial concentration, and/or signaling fidelity. However,
although MAPKs are known to regulate the action of
several membrane proteins and receptors, none of these
scaffold proteins are themselves membrane proteins,
requiring additional mechanisms for colocalization of
the scaffold protein, the membrane protein, as well as
the kinases. Moreover, most of the available molecular
insights are from structures of kinases in complex with
folded domains or with small peptides of the scaffold
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proteins, and details regarding scaffolding by non-globular
proteins are lacking.
MAPKs are S/T kinases that interact with targets and
regulators via two types of domains, D-domains and
F-sites [7–11]. D-domains, also known as docking
sites for ERK and JNK, LXL (DEJL) domains, or kinase
interaction motifs (KIMs) have the canonical sequence of
2–5 basic residues (R/K), spaced by 1–6 residues to a
hydrophobic motif ΦXΦ, where Φ is generally V, L,
or I [8, 9]. D-domains are found in MAPK substrates
such as the transcription factor Elk-1 and p90 riboso-
mal S kinase (RSK1-3), as well as in other MAPK tar-
gets [8, 9, 11]. In ERK2, D-domains interact with the
D-domain recognition site also known as the CD/ED
(common docking domain/glutamate/aspartate dock-
ing) domain, located more than 10 Å from the active
site [8, 9, 11]. The F-site recruitment site in ERK2 is
much less studied and incompletely understood. It
binds to F-sites, also called DEF (docking site for
ERK, FXFP)-domains with the canonical FXFP se-
quence [12]. F-sites allow for aromatic residues at the
P1 (F, W) and P3 positions (F, Y, W) [13], and F-sites
have been reported in substrates such as Elk-1 (FQFP)
[14] and c-Fos (FTYP) [15], and within the nucleoporin
FG-repeats (FXFG) [16, 17]. So far the only structure
available of an F-site recruitment site-interacting protein
is that of ERK2 in complex with the 15 kDa phosphopro-
tein enriched in astrocytes (PEA-15), which notably lacks
any of the above-mentioned motifs [18].
The plasma membrane Na+/H+ exchanger 1 (NHE1,
SLC9A1) is a major regulator of pH and volume in es-
sentially all cells studied. Furthermore, NHE1 is involved
in the regulation of cell proliferation, survival, motility,
and other essential physiological processes, and its dys-
regulation contributes importantly to major human ma-
lignancies, including cancer and cardiovascular diseases
[19, 20]. Numerous hormones and growth factors acting
via receptor tyrosine kinases or GTP-binding protein-
coupled receptors can elicit posttranslational regulation
of NHE1 [21–23]. The MAPKs ERK1/2, p38 MAPK, and
c-Jun N-terminal kinase (JNK) are widely implicated in
NHE1 regulation [24–28], and direct phosphorylation of
human (h) NHE1 by ERK1/2 was previously proposed
based on 32P measurements [25] and mass spectrometry
[29]. Conversely, NHE1 has been reported to regulate
signaling through regulation of ERK1/2 and p38 MAPK
activity [26, 28, 30–32], and yeast two-hybrid screens
have suggested the interaction of NHE1 with several
members of the MAPK hierarchy [33]. However, with
the exception of the interaction with B-Raf [34], evi-
dence from mammalian systems is lacking, and the pos-
sible sites of NHE1-MAPK interaction, its structural
details, and possible functional consequences are unex-
plored. We recently showed by PONDR and DISOPRED
predictions, as well as by nuclear magnetic resonance
(NMR) spectroscopy and other biophysical techniques,
that the distal ~ 130 residues of the hNHE1 C-terminal
intracellular domain (hNHE1cdt), containing most of
the known NHE1 phosphorylation sites, are intrinsically
disordered (ID) [35, 36]. To our knowledge, no studies
have yet addressed the mechanisms through which
MAPKs interact with ID proteins (IDPs), although about
one third of all proteins in higher eukaryotes contain
significant ID regions (IDRs) [37], and ID is abundant in
cellular signalling [38], scaffolding [39], as well as in
MAPKs themselves [40].
Here, we demonstrate that hNHE1 acts as an ERK2
membrane protein scaffold in vivo that is necessary for
ERK2 activation via direct interactions, and we show
that loss of scaffolding by hNHE1 leads to decreased
ERK2 activation. Using NMR spectroscopy we show that
NHE1 scaffolds inactive (ia) ERK2 in a “shuffle complex”
that involves a D-domain and two non-canonical F-sites.
We characterize the order and kinetics of both previ-
ously reported and novel ERK2-mediated phosphoryla-
tions of hNHE1 in vitro. Our findings provide a
molecular mechanism for the widely recognized and
functionally important scaffolding function of hNHE1,
and give mechanistic insight into the regulation of ERK2
activity by the intrinsically disordered hNHE1cdt.
Results
The recently suggested links between hNHE1 and
ERK1/2 prompted us to investigate whether ERK1/2 and
NHE1 directly interact in a cellular context. Using AP-1
cells (which lack endogenous NHE1 [41]) stably express-
ing full-length WT hNHE1, we asked if hNHE1 and
ERK1/2 engage in a direct interaction in vivo. Inter-
action was assessed using in situ proximity ligation assay
(PLA), which interrogates close interaction (<40 nm) be-
tween proteins (Fig. 1). As seen, the detection of mul-
tiple PLA puncta when cells were incubated with both
NHE1 and ERK1/2 antibodies revealed the presence of
hNHE1-ERK1/2 complexes in AP-1 WT hNHE1 cells
(Fig. 1a), compared to a much lower signal in negative
controls incubated with one antibody only (Fig. 1b). Data
from multiple experiments are quantified in Fig. 1c,
demonstrating that the PLA signal is significantly greater
in NHE1-ERK antibody-labelled cells than in negative
controls. Thus, these data show that hNHE1 and ERK1/
2 directly interact in the cell.
The disordered tail of hNHE1 interacts with iaERK2
Scrutinizing the intracellular domain of NHE1 by in
silico methods for potential ERK1/2 interaction sites
identified three potential D-domains in the intrinsically
disordered region (IDR) [35, 36], [LAYEPKEDLPVI-
TIDP]706–721 (D1), [LVNEELKGKVLGLSR]732–746 (D2),
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Fig. 1 Direct interaction between ERK2 and NHE1 in vivo and in silico. a Proximity ligase assay carried out in AP-1 WT hNHE1 cells treated with
NHE1 and ERK1/2 primary antibodies. Proximity ligase signal appears as red dots and the merge image highlights the interaction between NHE1
and ERK. F-actin was stained with phalloidin488. Scale bars represent 10 μm. Data are representative of three independent replicates. b Proximity
ligase assay carried out in AP-1 WT hNHE1 cells. As a negative control, cells were only treated with NHE1 primary antibodies and the appearance
of the red dots indicates unspecific binding. F-actin was stained with phalloidin488. Scale bars represent 10 μm. Data are representative of three
independent replicates. c Quantification of PLA data was carried out in ImageJ. PLA signal from at least ten different image areas in each
experiment were counted by particle analysis and the average PLA signal per cell was plotted in the bar graph. Data are representative of three
independent replicates. d ERK1/2 docking motifs, D-domain and F-site. Φ indicates hydrophobic amino acid residues (typically L, V, or I), and X
any other amino acid. e Overall NHE1 topology and localization of putative D-domains and ERK2 phosphorylation sites in the hNHE1cdt. The
positions of identified D-domains as well as predicted (S/T)P-phosphorylation sites are indicated by stars. Insert: alignment of the consensus ERK2
phosphorylation sites in hNHE1; (S/T)P sites indicated by grey background. f Alignment of hNHE1 D-domains to known D-domains. The consensus
hydrophobic and positively charged residues are highlighted in yellow and blue, respectively. g Sequence conservation of putative D-domains in
NHE1cdt in various species. D1, D2, and D3 are indicated with grey bars above the alignment. The solid horizontal line separates tetrapods (top)
from teleosts (bottom) [35]
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and [LEQKINNYLTVPA]676–688 (D3) (listed in the order
of stringency) (Fig. 1d–g). The previously described con-
served TV-box is part of the D3-domain [35], and this
D-domain is the only one conserved throughout NHE1
evolution (Fig. 1g). Since ERK1 and ERK2 are 84 % iden-
tical by sequence and share many if not all functions
[42], and ERK2 is the more widely studied enzyme of
the two, we focused in vitro studies on ERK2. To dis-
criminate between the roles of each D-domain, we inves-
tigated the interaction between the disordered tail of
NHE1 (residues I680-Q815 (hNHE1cdt)) and recombi-
nantly produced human iaERK2 by NMR spectroscopy,
which previously had provided insight into the transient
structure and conserved regions of hNHE1cdt [35]
(Fig. 2a). First, we measured perturbations of chemical
shifts and peak intensities of the hNHE1cdt WT arising
from addition of iaERK2 to a 1:1 molar ratio using
15N,1H-HSQC spectra (Fig. 2b, c). Signals from all resi-
dues of the D3-domain disappeared, and decreased in-
tensities and chemical shift perturbations were observed
in the C-terminal neighbouring residues, suggesting this
domain engages in the interaction. Additionally, two Phe
residues in the distal end of hNHE1cdt [PFFPKGQ]809–
815, as well as a Phe residue within a potential substrate
site, [FTP]778–780, were highly perturbed. Importantly, al-
though the latter resembles a substrate site, both are
reminiscent of the canonical ERK F-site motif, suggest-
ing several interaction sites between hNHE1cdt and
iaERK2. Additional yet minor perturbations were ob-
served in the linking regions between these sites, which
were partially caused by slight pH variations (Additional
file 1: Figure S1a). Since some residues in D1 are un-
assigned due to their overlap in the NMR spectra, and
perturbations were observed close to this site (Fig. 2b,
c), we cannot exclude D1 to also contribute to the inter-
action. Lastly, as Escherichia coli expression of ERK2
can lead to autophosphorylation of Y187 [43], we
assessed the level of ERK2 autophosphorylation by na-
tive PAGE, showing that more than 80 % of ERK2 is
non- and less than 20 % mono-phosphorylated
(Additional file 1: Figure S1b). To ensure that this had
no effect on the interaction with NHE1cdt we fully de-
phosphorylated ERK2 with the Tyr phosphatase HePTP
and re-analysed the interaction, which gave an identical
binding profile (Additional file 2: Figure S2a, b), in
accordance with the low activity of the ERK2 mono-
phosphorylated state [44]. In conclusion, NHE1cdt inter-
act with iaERK2 through multiple contact sites involving
the D3-domain, as the dominating D-domain, and two
F-sites (F1, FTP780 and F2, FFP811).
We next investigated whether interfering with any of
these contact sites would affect the interactions and first
exploited the knowledge that MAPK interaction is se-
verely perturbed by mutations of ΦXΦ to AXA in D-
domains [45]. Hence, we constructed AXA variants of
all three D-domains alone and in combination, both in
the full-length hNHE1 (hNHE1-D1-AXA, hNHE1-D2-
AXA, etc.) for cellular studies and in hNHE1cdt (D1-
AXA, D2-AXA, D3-AXA) for in vitro studies. In D3-
AXA, chemical shift perturbations in the two F-sites
upon ERK2 addition were preserved in the interaction
with iaERK2, whereas no perturbations were observed in
the AXA-mutated D3-domain, implying that this site is
important for the interaction (Fig. 2e and Additional file
2: Figure S2c). No notable effects of D1- and D2-AXA
substitutions were observed (Additional file 2: Figure
S2d–e), arguing against their involvement in the interac-
tions. This data also indicated that the F-sites interacted
with iaERK2 independently of the D-domain. To assess this
further the F-sites were individually mutated by substituting
FTP778–780 with ATP778–780 (denoting the F1-A variant)
and FP811–812 with AA811–812 (denoting the F2-AA variant).
Both F-site variants showed strongly decreased chem-
ical shift perturbations at the mutation sites upon
ERK2 addition, leaving the other F-site and the D3-
domain unaffected (Fig. 2f–g and Additional file 2:
Figure S2f–g). This conclusively identified all three
sites as ERK2 interaction sites. Further, substitutions
at each site left the other sites unaffected, indicating
that these regions of hNHE1 interact independently
with iaERK2.
NHE1 does not fold upon binding to ERK2 but may be a
flexible wrapper
To further address how hNHE1cdt interacted with
iaERK2 we analysed the complex by size exclusion chro-
matography (SEC) and compared elution profiles with
those of the individual proteins (Additional file 3: Figure
S3a–c). Since hNHE1cdt is an IDR, it has a larger hydro-
dynamic radius than iaERK, and hNHE1cdt thus eluted
first from the column. Subtracting individual runs from
that of the mixture revealed a broad peak with an elu-
tion volume smaller than that of iaERK2, yet larger than
that of hNHE1cdt, suggesting that hNHE1cdt folds or
wraps around iaERK2. Circular dichroism (CD) spectro-
scopic analyses (Additional file 3: Figure S3d), as well as
NMR chemical shift analyses (Fig. 2b), did not indicate
folding upon binding formation of significant secondary
structure, suggesting that hNHE1cdt forms a relatively
extended structure around iaERK2. To substantiate this
conclusion, we recorded 15N transverse relaxation rates
of the unbound (R2
free) and the iaERK2-bound hNHE1cdt
(R2
bound), and analysed their differences (Fig. 2d). Since
D3 residues broadened beyond detection in the complex,
their R2 values could not be extracted. However, for resi-
dues interacting with iaERK2, a significant increase in R2
rates is expected compared to those of hNHE1cdt alone,
due to the larger radius of gyration of the complex or
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due to chemical exchange between different states. In-
deed, residues from both F-sites had substantially larger
R2 rates in the complex compared to hNHE1cdt alone,
and many residues between these sites were also affected,
although not to the same extent. This result supports the
SEC results and suggests a substantial interaction area
between the two proteins.
The loss of NMR signal upon binding imposes a chal-
lenge for obtaining affinity constants. Although NMR
peak intensities are only directly proportional to the
populations when all states can be accounted for, they
may provide apparent upper-limit affinities. From a titra-
tion of hNHE1cdt with iaERK2, global fitting of intensity
changes using residues LTV684–686 of the D3-domain
Fig. 2 Inactive ERK2 interacts preferably with the D3-domain and two F-sites of hNHE1cdt. a Position of transient helices (black and dark grey bars,
see panel h), TV- and LSD-boxes (light grey bars), predicted D-domains and F-sites (red bars), as well as ERK2 phosphorylation sites (stars) in the
hNHE1cdt. b Combined chemical shift perturbations Δδ(15N,1H) of WT hNHE1cdt by iaERK2 interaction. c 15N,1H-HSQC peak intensity ratios of
hNHE1cdt WT in the presence/absence of iaERK2. d Difference in relaxation rates ΔR2 between hNHE1cdt and NHE1cdt:iaERK2. e–g
15N,1H-HSQC
peak intensity ratios of e hNHE1cdt D3-AXA, f hNHE1cdt F1-A, and g hNHE1cdt F2-AA in the presence/absence of iaERK2. h Internally urea
referenced secondary Cα chemical shifts (ΔδCα) of WT hNHE1cdt identify the presence of several transient helices (ΔδC’ in Additional file 2: Figure S2h).
● indicate the position of prolines, □ unassigned residues, and blue box severe peak overlap
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gave a Kd
app of 16 ± 2 μM, while the other interaction
sites had relatively lower affinities with apparent affin-
ities, Kd
app of 86 ± 26 μM (F1, F778) and 69 ± 14 μM (F2,
F811) (Additional file 4: Figure S4). Attempts to substan-
tiate this and obtain stoichiometries by isothermal titra-
tion calorimetry or microscale thermophoresis were
unsuccessful, due to limited stability of concentrated
ERK2, as well as adhesion of ERK2 to the capillary
tubing. Instead, to determine the stoichiometry of the
interaction we used non-denaturing mass spectrometry,
allowing the non-covalent complex to be captured at
low micromolar concentration. Deconvolution of the
spectrum using in-house software [46] revealed three
main charge state envelopes, corresponding to hNHE1cdt
(14,787.89 Da), iaERK2 (42,367.39 Da), and from the 1:1
complex (57,175.50 Da) (Fig. 3a). A minor population of
iaERK2 dimers was also detected (84,695.91 Da), most
likely due to the presence of a hexahistidine-tag, as noted
[47]. These data unequivocally showed that hNHE1cdt
and iaERK2 form a 1:1 complex, fully in-line with the per-
turbation of the relaxation times and the size exclusion
data. Collectively, these data indicated that NHE1cdt binds
to ERK2 with medium affinity, through at least three inde-
pendent contact sites forming a 1:1 complex.
Finally, we used the NMR chemical shifts and relaxation
data together with known structures of iaERK2 complexes
to model the hNHE1cdt-iaERK2 interaction (Fig. 3b).
When modelled at the D-domain recognition site of
iaERK2, each individual D-domain (D1, D2, or D3) when
bound to the D-domain recognition site allowed for either
of the F-sites (F1 or F2) to reach the F-site recognition
site. In each case the model predicted long ID linkers
between the binding sites, which were long enough to
allow NHE1 to wrap around iaERK2. This is in accordance
with the NMR data and supports their uncoupled behav-
iour. Collectively, these data suggest that hNHE1cdt could
interact with iaERK2 in a tripartite 1:1 interaction
exploiting a D-domain (D3) and two F-sites.
ERK2 phosphorylates hNHE1cdt at six consensus sites in a
distinct order and with different kinetics
In silico analysis predicted six canonical ERK2 substrate
sites in hNHE1cdt (Fig. 1e), several of which were previ-
ously shown to be phosphorylated in vivo [48] and in
vitro [29]. We therefore used active ERK2 (aERK2) and
time-resolved (TR) NMR spectroscopy to investigate
whether hNHE1cdt could be phosphorylated by aERK2
in vitro, and how the individual D-domains and F-sites
might contribute to this. Addition of catalytic amounts
of aERK2 to 15N-labelled hNHE1cdt resulted in changes
in chemical shifts diagnostic of specific S/T-phosphoryl-
ation events [49, 50] (Fig. 4a, b). From NMR assign-
ments of the fully phosphorylated state of hNHE1, we
identified all six sites (S693, S723, S726, S771, T779, and
S785) to be phosphorylated in a distinct temporal order
and with different rate constants (Fig. 4c–k). Phosphory-
lated (P) residues S693P and T779P appeared first and
simultaneously. After a lag phase, when S693P and
T779P had essentially reached saturation, S785P, S723P,
S726P, and S771P appeared in close succession (Fig. 4d,
f ). S771P was the last to appear and did not reach satur-
ation in the time frame of the experiment. Two-state be-
haviour was observed for S693 and T779 (shown for
T779 in Fig. 4g), whereas phosphorylation of S723 and
S726 showed more complex behaviour with interlinked
rates. This can be inferred from the observation of two
intermediates, i.e. phosphorylation of the neighbour in
the self-unphosphorylated state, and vice versa (Fig. 4d,
Fig. 3 Native mass spectrum (MS) and molecular model of the hNHE1cdt:iaERK2 complex. a Non-denaturing mass spectrum of the hNHE1-ERK2
complex, acquired from 200 mM ammonium acetate. Deconvolution was performed using the UniDec software and the individual charge series
fits are displayed below, corresponding to NHE1 (blue), ERK2 (green), NHE1:ERK2 complex (red), and minor contribution of ERK2 dimer (orange). b
Proposed model for the hNHE1-ERK2 interactions. The hNHE1cdt interacts with ERK2 at three sites, exploiting a D-domain and two F-sites (shown
in green and blue, respectively). At the D-domain recognition site, K679, L684, and V686 of the hNHE1cdt D3-domain, as well as D318, D321, Y128,
and H125 of the iaERK2 D-domain recognition site are shown as sticks
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h–j). To determine if S693 and T779 acted as priming
sites for subsequent phosphorylations of the four other
sites, these were mutated to alanines in two different
variants (S693A and T779A) and the phosphorylation
kinetics repeated. The same order of phosphorylation
was observed (Additional file 5: Figure S5a, b), which in-
dicated that the relative order of phosphorylation
depended solely on substrate specificity and/or recogni-
tion domain affinity, and that neither S693 or T779
acted as priming sites. In summary, these results demon-
strate complex behaviour of hNHE1cdt phosphorylation
by aERK2, with a defined order, and additional inter-
mediate states. S693 and T779 were the first and most
reactive aERK2 phosphorylation sites in hNHE1cdt, but
did not act as priming sites, followed by S723 (I1), then
S785 simultaneously with S726 (I2), followed by dually
phosphorylated S723 and S726, and lastly S771.
D-domains play differential roles in scaffolding and
activation
We subsequently asked whether the D-domains and F-
sites affected the NHE1 phosphorylation pattern in vitro,
as well as the scaffolding function in vivo. All sites were
analysed in vitro using the AXA mutations of the D-
domains (D3 alone and D1D2 combined) and alanine
mutations of the F-sites, and were analysed together
with WT hNHE1 using the same batch of aERK. For all
variants, all six S/T-sites were phosphorylated in the
same order as in the WT hNHE1, but with altered kinet-
ics (Fig. 4l, Table 1, and Additional file 5: Figure S5c).
Analysing those data is not trivial. Since S723 and S726,
as well as S771, T779, and S785 are close in sequence,
they sense the phosphorylation state of the neighbour,
leading to intermediate states with altered dynamics
and/or chemical environment. The T779 phosphorylation
(See figure on previous page.)
Fig. 4 Active ERK2 phosphorylates six (S/T)P-sites in hNHE1cdt in a distinct order and with different kinetics. a 15N,1H-HSQC spectra of
unphosphorylated (blue) and ERK2 phosphorylated hNHE1cdt WT (red). Addition of catalytic amounts of aERK2 to 15N-labelled hNHE1cdt resulted
in diagnostic changes in chemical shifts evident of specific S/T-phosphorylation events. b Zoom on S/T and SP/TP regions of a. Red labels/arrows
indicate phosphorylation-induced peak shifts, and blue arrows/labels peak shifts of neighbouring residues sensing phosphorylation. c Time courses
of hNHE1cdt phosphorylations and order of peak appearances. d Phosphorylation time courses. Zoom i–v on boxes in b. Peaks of unphosphory-
lated (left panel) and phosphorylated states (right panel) simultaneously disappear/appear with time, in a distinct order. Dashed lines encircle mul-
tiple peaks of the same residue reporting on distinct phosphorylation states. Stars indicate position of intermediates. e Relative positions of ERK2
phosphorylation sites (stars) to D-domains and the F-sites in hNHE1cdt f Changes of peak intensities with time reported on the phosphorylation
rates at the individual sites. S693 and T779 were the first and most reactive aERK2 phosphorylation sites in hNHE1cdt, followed by S723 (I1), then
S785 simultaneously with S726 (I2), followed by dually phosphorylated S723 and S726, and lastly S771. g Kinetics of T779 phosphorylation shown
by peak disappearance of D776 and V777 concomitant with peak appearance for V777* and T779P. Apparent rate constants can be extracted by
fitting the unphosphorylated disappearing peak or the appearing phosphorylated peak of either the phosphorylated residue or close neighbours,
and should, for a two-state reaction, be the same irrespective of which peak is used for fitting. Two-state behaviour was observed for S693 and
T779. h–j Phosphorylation of S723 and S726 showed more complex behaviour with interlinked rates. These residues are so close that a
neighbouring phosphorylation event would influence their chemical shifts, leading to the observation of intermediates, i.e. phosphorylation of
the neighbour in the self-unphosphorylated state, and vice versa (see also panel d). The observation of two intermediates I1 and I2 suggested
parallel phosphorylation of S723 and S726. Both peaks of the dually unphosphorylated state disappeared with faster rates than the final peaks
from the dually phosphorylated state appeared. Thus, the apparent phosphorylation rates of each site were highly dependent on the phosphorylation
state of the neighbour, i.e. k1 and k4 as well as k2 and k3 are not identical. I1 appeared first with a rate similar to the fast decay of the unphosphorylated
states (k1, see also Table 1), whereas I2 appeared concomitantly with the dually phosphorylated state but much slower (k2 and k3) and with low
intensities. Thus, although both orders of phosphorylation were observed, the main path was via intermediate I1, i.e. phosphorylation of S723 first,
followed by phosphorylation of S726. k The weak peaks reporting on the unphosphorylated states of S771 and S785 initially gained intensity before
starting to decrease due to phosphorylation (shown for S771). As peak intensities are strongly dependent on dynamics, this observed increase may
result from altered dynamics caused by the nearby phosphorylation of T779. l Apparent rate constants for the individual phosphorylation sites and the
effect of D-domain and F-site mutations. Docking site mutations do not change the order of phosphorylation events, yet modulate the individual rates
in a distant dependent manner. Based on single measurements and standard deviations from the exponential fits, the apparent rates are significantly
different except for S693 WT compared to D3-AXA, S771 WT compared to F2-AA, and S785 WT compared to D1D2-(AXA)2 (one-way ANOVA)
Table 1 Apparent rate constants, kapp for hNHE1cdt phosphorylation by aERK2, and effect of D-domain and F-site mutations
P-site kapp (h
-1)
WT D3-AXA D1D2-(AXA)2 F1-A F2-AA
S693 0.3489 ± 0.0101 0.3488 ± 0.0112 0.3193 ± 0.0109 0.3000 ± 0.009 0.4435 ± 0.0177
S723/S726a 0.0821 ± 0.0018 0.0592 ± 0.0010 0.0610 ± 0.0011 0.0741 ± 0.0015 0.1274 ± 0.0018
S771 0.0088 ± 0.0015 0.0070 ± 0.0011 0.0066 ± 0.0011 0.0047 ± 0.0008 0.0088 ± 0.0015
T779 0.1648 ± 0.0022 0.1413 ± 0.0017 0.1572 ± 0.0021 0.1473 ± 0.0024 0.1441 ± 0.0018
S785 0.0305 ± 0.0016 0.0325 ± 0.0016 0.0302 ± 0.0017 0.0088 ± 0.0019 0.0120 ± 0.0021
aFitting of S723 and S726 individually would require fitting to biexponentials due to their extensive crosstalk, which in turn reduces fitting accuracy. Therefore,
only decrease of the S723 peak intensity was fitted, which reports on both S723 and S726 phosphorylation due to their crosstalk
Hendus-Altenburger et al. BMC Biology  (2016) 14:31 Page 8 of 17
site overlaps with the F1-site, so the effect of F1 mutation
may be either due to the loss of the interaction or due to
the altered intrinsic affinity of the phosphosite. Also, the
slow phosphorylation sites S771 and S785 may be affected
by altered kinetics of the fast sites due to simple intramo-
lecular substrate competition.
In detail, S693 phosphorylation was not affected by the
D3-AXA mutation, but was slowed down by the D1D2-
(AXA)2 and F1-A variants, and accelerated by the most
distant F2-AA variant. Similarly, S723/S726 phosphory-
lations were slowed down by all mutations except the
most distant one, F2-AA that again led to accelerated
rates. T779 phosphorylation was slowed down by all mu-
tations, and S785 was strongly decreased by both F-site
mutants. Taken together, mutations of the D-domains
and F-sites affected phosphorylation in a distance
dependent manner. In three cases (S693 and S723/S726
phosphorylation of the F2-AA variant) the rate of phos-
phorylation went up, suggesting that the presence of this
site was inhibitory. In all three cases this occurred for
the site furthest away from the mutation, reflecting com-
petition between sites. This suggests that the D-domains
and F-sites are not mandatory for phosphorylation,
but rather exert regulatory roles, and that each site uses
the most optimal ERK2 interaction site to become
phosphorylated.
To determine whether the D-domain and F-site vari-
ants affected hNHE1-ERK2 interaction in a cellular con-
text we used immunofluorescence analysis, which
revealed that hNHE1 localized predominantly to the
plasma membrane region of AP-1 cells, although some
intracellular hNHE1 labeling was also seen (Fig. 5a), fully
Fig. 5 NHE1 co-localizes with ERK2 shown by immunofluorescence. a Immunofluorescence images of AP-1 cells (hNHE1 WT, D3-AXA and F2-AA)
treated or not for 15 min with EGF (100 ng/ml). Merged images were zoomed to highlight the co-localization of ERK1/2 and NHE1 (white arrowheads).
All other variants are shown in Additional file 6: Figure S6. Data are representative of three independent biological replicates. b Representative line
scans across membrane areas of images as in a. Line scans were performed using Olympus image analysis software. The figure shows the pixel
intensities at each wavelength over the line shown, in the absence and presence of EGF as shown. Data are examples based on analysis of at least 60
cells in three to four independent replicates per condition. c Summary of line scan analysis data for all variants. The figure shows the percentage of
cells with NHE1-ERK1/2 co-localization in both membranes, based on the experiments illustrated in b. Data are shown as mean percentage with SEM
error bars, based on analysis of at least 60 cells in three to five independent replicates per condition. §§ and §§§, p < 0.01 and p < 0.001, respectively,
relative to AP1 + EGF; * p < 0.05 relative to own control in absence of EGF. Two-way ANOVA, Šídák’s multiple comparisons test
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consistent with previous reports [22, 51] and with the
PLA studies (Fig. 1a, b). Stimulation with epidermal
growth factor (EGF, 100 ng/ml) induced distinct plasma
membrane ruffles, to which hNHE1 clearly localized, in
congruence with its role in cell motility [52, 53], and
similar to the localization of NHE1 to prolactin-induced
ruffles, which we recently demonstrated [54]. ERK1/2 lo-
calized diffusely in the cytosol and nucleus, as well as in
plasma membrane regions, where it partially co-
localized with hNHE1 (white arrowheads). In a cellular
context we refrained from using the F1-variant, as the
phenylalanine is part of a phosphorylation site (FTP778–
780), thus complicating the interpretations. Similar to
WT hNHE1, all hNHE1 variants localized predominantly
to the plasma membrane region, suggesting that the mu-
tations did not affect NHE1 membrane targeting (Fig. 5
and Additional file 6: Figure S6). Compared to cells ex-
pressing WT hNHE1, co-localization with ERK1/2 was
unaltered both under basal and stimulated conditions in
cells expressing hNHE1-D1D2-(AXA)2 (Fig. 5c and Add-
itional file 6: Figure S6b), suggesting that D1 and D2 are
not important for in vivo scaffolding and in congruence
with their role in phosphorylation (Fig. 4l). Interestingly,
whereas stimulation by EGF tended to increase co-
localization in cells expressing WT hNHE1 and D1D2-
(AXA)2, the opposite was true in cells expressing the
D3-AXA, D1D2D3-(AXA)3, and F2-AA-variants (Fig. 5b,
c and Additional file 6: Figure S6a, b). Hence, in these
variants, a loss of colocalization was seen, which sug-
gests that scaffolding as well as the dynamics of the
hNHE1-ERK2 interaction are dependent on both the
D3-domain and the F2-site. These data fully support the
in vitro NMR data and highlight both the D3-domain
and F2-site as important for scaffolding.
NHE1 regulates ERK2 phosphorylation status in a cellular
context
To address whether NHE1 regulates ERK2 activity, we
next assessed ERK1/2 activation by determining relative
T202/Y204 (ERK1)-T185/Y187 (ERK2) phosphorylation,
corresponding to ERK1/2 activation. Untransfected AP-1
cells, or AP-1 cells stably expressing WT hNHE1, were
exposed to EGF (100 ng/ml) to induce ERK1/2 activity
(e.g. [55]; Fig. 6a, b). As seen, despite the known low
level of EGF receptor expression in Chinese hamster
ovary (CHO)-derived cells such as AP-1 cells, stimula-
tion of cells expressing WT hNHE1 with EGF evoked a
modest but significant increase in ERK1/2 phosphoryl-
ation at these sites, i.e. ERK1/2 activation. Importantly,
the presence of WT hNHE1 was necessary for detectable
activation of ERK1/2 by EGF. This suggests that hNHE1
is important for ERK1/2 activation in this context.
To assess whether the interaction-site mutations
would affect NHE1-regulated ERK2 activity, we exposed
Fig. 6 NHE1 regulates the phosphorylation status of cellular
ERK1/2. ERK1/2 phosphorylation in untransfected AP-1 cells or
AP-1 cells expressing WT and variant hNHE1, as indicated. Cells
were stimulated or not with human recombinant EGF (100 ng/
ml) for 15 min. a Representative immunoblots of p-ERK1/2
(T202/Y204 (ERK1)-T185/Y187 (ERK2) phosphorylation) and total
ERK1/2 under the conditions shown. The arrows indicate ERK1
(top) and ERK2 (bottom), respectively. b Summary data from
three to eight independent biological replicates per condition.
Blots were scanned, and band intensities quantified using
Un-Scan-IT Graph Digitizer software (Silk Scientific), as described
in the “Methods”. Quantified data are shown as means with SEM error
bars, normalized to those in untransfected, unstimulated AP-1 cells. *,
**, and ***, p < 0.05, p < 0.01, and p < 0.001, respectively, compared to
untransfected control; #, ##, and ###, p < 0.05, p < 0.01, and p < 0.001,
respectively, compared to the same cells in absence of EGF. Two-way
ANOVA, Holm-Šídák’s multiple comparisons test
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untransfected AP-1 cells or AP-1 cells expressing WT
and variant hNHE1s, to EGF and determined ERK1/2
activity ([55]; Fig. 6a, b). Compared to cells expressing
WT hNHE1, cells expressing hNHE1-D3-AXA, hNHE1-
D1D2D3-(AXA)3, or hNHE1-F2-AA variants exhibited a
significant decrease in relative EGF-induced ERK1/2 phos-
phorylation (pERK1/2; Fig. 6b). These data show that
hNHE1 is important for EGF-induced ERK1/2 activation
in a cellular context, in a manner dependent on its
D3-domain and F2-site. These data further support
that this at least in part reflects a scaffolding role of
hNHE1 involving the three independent low affinity
sites. Notably, the effects of the mutations on ERK1/
2-NHE1 co-localization and ERK1/2 activity are com-
parable if not identical, and mirrors the interaction
monitored by NMR spectroscopy.
Discussion
NHE1 activity after various stimuli is regulated by ERK1/
2, and the NHE1 C-terminal tail is directly phosphorylated
by ERK2 in vitro [29] and in vivo [25]. Vice versa, NHE1
can regulate ERK1/2 activity [26, 28, 30–32], yet molecu-
lar details and mechanistic understanding of their inter-
action have been lacking. In conjunction with yeast two-
hybrid studies suggesting interaction of NHE1 with
MAPKs [33], these studies led us to hypothesize that
NHE1 and ERK2 engage in direct physical interaction.
Supporting this hypothesis, we report here that ERK2 and
NHE1 interact directly in vivo as well as in vitro, and that
ERK2 phosphorylates multiple sites in hNHE1cdt. Based
on NMR analyses, in conjunction with various combina-
tions of D-domain and F-site mutations, we suggest that
hNHE1cdt scaffolds iaERK2 and that they interact in a
non-cooperative modular manner that involves a D-
domain (D3) and two F-sites. NMR titrations revealed the
affinity of the D3-domain to be in the low micromolar
range, in agreement with known D-domain affinities [7].
D-domain and F-site mutations did not prevent ERK2-
mediated hNHE1 phosphorylation in vitro, but altered its
kinetics. In vivo, hNHE1 and ERK1/2 co-localized at the
plasma membrane in a manner sensitive to ERK1/2 stimu-
lation, and mutations in the hNHE1 D3-domain and F-
site altered ERK1/2 activity. Thus, a central conclusion of
this work is that NHE1 and ERK2 directly interact and en-
gage in physical and functional reciprocal interactions.
This provides a novel molecular framework for under-
standing previous reports of both NHE1-mediated scaf-
folding and regulation of ERK1/2 [28] and ERK1/2-
mediated phosphorylation of NHE1 [25].
The organization of IDPs as “flexible wrappers” has
previously been suggested as a general scaffolding
mechanism [56], involved in bipartite interactions, for
example of Ste5 with the yeast MAPK Fus3 [57] and of
p21CIP1 with cyclin-dependent kinases [58]. Upon
identification of the F-site, a bipartite modular, non-
cooperative recognition system was originally suggested
for kinases with the D-domain and F-site acting inde-
pendently or in combination [12]. The tripartite (D-do-
main and two F-sites) interaction between hNHE1cdt
and iaERK2 uncovered here extends this concept. For
hNHE1, the multi-site interaction may function in a
manner analogous, but not identical, to a fuzzy complex
[59, 60], where several binding sites are at play concomi-
tantly, yet with none of the interactions seemingly affect-
ing each other. The “hot potato hypothesis” was
originally suggested by Perham in 1975 to describe the
handover of substrates and intermediates in multi-
enzyme complexes [61]. Indeed, the non-cooperative,
multi-site scaffold interaction between hNHE1 and
ERK2 may function similarly to holding a hot potato; the
sites do not cooperate to increase the affinity, but will
“shuffle” dynamically with sites being sometimes off,
sometimes on, and hence we term this type of scaffold
interaction a “shuffle complex” (Fig. 7).
NHE1 is, to the best of our knowledge, the first mem-
brane protein described to scaffold members of the
MAPK pathway, spanning all four levels of the MAPK
hierarchy [33]. Many soluble scaffold proteins acting to-
gether with, for example, G protein-coupled receptors
(GPCRs) and growth factor receptors, have been de-
scribed, but detailed interaction data have not provided
insight into how scaffolding and regulation are coupled. In
the cell, MEKs, phosphatases, and substrates all compete
for the D-domain recognition site on ERK2 [62], and it is
currently not known how NHE1 interacts with the other
MAPK members, including MEK, and assembles a signal-
ling complex. As NHE1 acts as a dimer in vivo [36, 63],
we propose that upon release of the D3-domain from one
NHE1 monomer due to competition with MEK, the shuf-
fle complex organization keeps ERK2 in place via scaffold-
ing by D-domains of the other NHE1 subunit in the
NHE1 dimer, or by the F-sites (Fig. 7a, b). Furthermore, in
a potential cellular complex, the remaining D-domains as
well as F-sites will be available for further scaffolding of
other members of the MAPK hierarchy (Fig. 7c), as sug-
gested by yeast two-hybrid screens, potentially MEK, al-
though this remains to be explored.
NHE1 is the first example of an ID substrate of ERK2
for which detailed interaction data now exist, and to the
best of our knowledge, no other IDP or IDR has to date
been experimentally linked to ERK2 phosphorylation or
scaffolding. It has been noted that the D-domain of the
tyrosine-phosphatase PTP-SL resides in a region with
high disorder propensity [64]. Disorder predictions of
the nuclear pore protein Tpr (Additional file 7: Figure
S7) show its ERK2-interacting F-site to reside in an IDR,
similar to the nucleoporin FG-repeat regions and to
hNHE1cdt. Thus, it appears that the F-site recruitment
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site interaction may be frequently exploited by IDPs.
However, it remains to be seen whether the multi-site
shuffle interaction is a novel canonical IDP/IDR-ERK2
interaction mode or if it is a unique scaffolding function
specific to NHE1.
All six putative ERK2 phosphorylation sites of
hNHE1cdt were phosphorylated by aERK2 in vitro
(S693, S723, S726, S771, T779, and S785). Previous in
vivo phosphoproteomics have mapped phosphorylation
at five of these sites, yet without identification of the
responsible kinases, and with no information on the
sequence of individual phosphorylation events [48, 65].
Further, some of these sites, i.e. S693, T779, and S785,
were previously identified upon in vitro phosphorylation
of NHE1 by ERK2 [29]. No non-canonical phosphoryl-
ation was detected in the present study, in contrast with
previous reports identifying S766, S770, and S771 as
ERK-dependent NHE1 phosphorylation sites [25, 29].
While it is possible that additional complexity may be
introduced in the in vivo setting, our data underscore
the major advantage of NMR for direct identification of
phosphorylation sites.
Physiological roles have been proposed for all six
phosphorylations, although their interplay and dynamics
have never previously been assessed. S723 and S726
(corresponding to S722 and S725 in rabbit NHE1) were
reported to be phosphorylated by p38 MAPK in murine
pro-B-cells [66], and phosphorylation of S726 was sug-
gested to mediate apoptosis-induced alkalinization by
NHE1 [67]. Based on studies of NHE1 mutants
expressed in NHE1-deficient CHO cells, S771 was re-
ported to mediate ERK-dependent NHE1 activation [25],
and later, S771, T779, and S785, but not S693, S723, or
S726, which were assigned roles in ERK-dependent
NHE1 phosphorylation after sustained acidosis in renal
cells [68]. In Amphiuma erythrocytes, phosphorylation
of residues corresponding to S693 and S785 (S701 and
S783) were detected by MS, where S785 (S783) was con-
stitutively phosphorylated [69]. The precise downstream
effects of these phosphorylations are not currently
known, but they are likely to both impact NHE1 struc-
tural dynamics and hence activity, and to contribute to
the scaffolding role of NHE1 in regulation of ERK, hence
fine-tuning cellular ERK signaling. Timing of signalling
events is crucial for many cellular functions, and phos-
phorylation events that are interdependent or distribu-
tive with very different rate constants are possible ways
of controlling signal duration and strength. Indeed, it
has been suggested that such temporally ordered phos-
phorylations serve as platforms for signal integration
[55]. Our findings provide evidence for a distinct tem-
poral order of ERK2 phosphorylation of hNHE1cdt with
the occurrence of specific intermediates. These interme-
diates could function as tightly regulated docking sites
or thresholds that convert graded signals to switch-like
responses [70]. Such dynamics in ERK2 signalling have
been observed to affect the half-life of an ERK2 down-
stream effector, the transcription factor c-Fos [15].
Timed phosphorylation events in hNHE1cdt may
therefore similarly partake in control of the ERK2 sig-
nal duration. The hNHE1cdt has other confirmed
phosphorylation sites than those demonstrated in the
present study, and many more putative ones [36],
several of which are close to the ERK2 interaction
sites, for example S703, phosphorylated by RSK [27].
These sites may mediate interactions with other binding
partners, introducing additional layers of complexities, for
example of pathway crosstalk.
Fig. 7 Scaffolding of ERK2 by the intrinsically disordered NHE1cdt via a “shuffle complex”. Suggested topology of the hNHE1cdt-iaERK2 complex
indicating the tripartite binding mode between hNHE1cdt and human iaERK2. a–b As NHE1 functions as a dimer in the cell, one or both NHE1s
in a dimer can shuffle an ERK1/2. c Alternatively, one NHE1 binds ERK1/2, whereas the other NHE1 in the dimer can scaffold other members of
the signalling complex. Alternating conformations are indicated encompassing the individual sites and combinations
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The close proximity of the primary S693 and T779
phosphorylation sites to the D3-domain and F1-site, re-
spectively, suggests regulatory role(s) for the interaction
of hNHE1cdt with, and phosphorylation by, ERK2.
Analogously, the first phosphorylation events in
hNHE1cdt (S693 and T779) may change the binding
mode and/or dynamics with ERK2 in a way that regu-
lates the phosphorylation of succeeding sites, although
we showed that they do not act as priming sites. The ef-
fects of hNHE1 variants on the phosphorylation kinetics
support the hypothesis that all sites are at play within
the shuffle complex, where the sites closest to the phos-
phorylation site are exploited for interaction with ERK2.
The current data does not allow us to evaluate whether
all six sites are phosphorylated during NHE1 activation.
Some sites, and most likely the slowest ones observed
here, may only react under certain physiological condi-
tions. We hypothesize that such conditional phosphory-
lations could be important for a rheostatic regulation of
both ERK2 and NHE1. Consequently, the results of this
work open a series of new questions, both regarding the
generality of shuffle complexes in scaffolding by IDPs,
but also concerning the functional roles and spatial and
temporal interconnectivity of the six identified phos-
phorylation sites in hNHE1.
Conclusions
In this work we have demonstrated that the intrinsically
disordered region of hNHE1 acts as a membrane scaffold
engaging ERK2 in a multi-site shuffle complex. We show
that the interaction is recapitulated in vivo, and that co-
regulation of hNHE1 and ERK2 manifests in distinct in vivo
effects on ERK1/2 activity and in vitro effects on hNHE1
phosphorylation. Our work provides a molecular mechan-
ism for the important scaffolding function of NHE1, and
characterizes a direct interaction between the intrinsically
disordered hNHE1cdt and ERK2, leading to hNHE1cdt
phosphorylation and regulation of ERK1/2 activity.
Methods
Cloning and mutagenesis
The human NHE1 C-terminal distal tail was extended
by six residues to M + I680-Q815 (hNHE1cdt; primer se-
quences presented in Additional file 8). The variants
D1D2-(AXA)2, D3-AXA, D1D2D3-(AXA)3, F1-A, and
F2-AA; S693A and T779A were prepared from the WT
hNHE1cdt plasmid and the WT full-length hNHE1 in a
pcDNA3.1 plasmid using a QuikChange II Kit (Strata-
gene). Final constructs were confirmed by sequencing
(Eurofins MWG Operon).
Protein expression and purification
The expression and purification of unlabeled human
ERK2, and of hNHE1cdt and 15N- and 13C,15N- labeled
hNHE1cdt were performed essentially as in [71]. All
protein preparations were > 95 % pure judged from
SDS-PAGE (Additional file 9: Figure S8). Details are
presented in Additional file 8: Supplementary materials
and methods.
Bioinformatics
Putative D-domains and consensus ERK2 phosphoryl-
ation sites in the hNHE1cdt were predicted by Scansite
3 [72] and aligned with Clustal Omega [73]. Intrinsic
disorder was analysed using PONDR-FIT [74] and
DISOPRED 3.1 [75].
NMR spectroscopy
All NMR spectra were recorded on Varian INOVA
750 MHz or 800 MHz 1H NMR spectrometers with a
5 mm triple resonance probe and a Z field gradient at
5 °C. Chemical shift referencing was relative to 4,4-di-
methyl-4-silapentane-1-sulfonic acid (DSS), and spectra
zero-filled, apodized, Fourier transformed, and baseline-
corrected in NMRDraw [76], and analysed manually in
CCPN Analysis [77]. Backbone resonance assignments
of hNHE1cdt and variants were done at 5 °C using 1.0–
1.5 mM samples of 15N,13C-hNHE1cdt in PBS pH 7.2,
0.5 mM DSS, 10 mM dithiothreitol (DTT), and 10 % (v/
v) 99.96 % D2O by standard 3D triple resonance experi-
ments as described [35]. Intrinsic random coil referen-
cing was done from assignments of hNHE1cdt in 8 M
urea from similar experiments. Chemical shift perturba-
tions of hNHE1cdt WT and variants from interaction
with unlabeled iaERK2 were determined using 0.1 mM
15N-labeled hNHE1cdt WT or variants in the presence/
absence of equimolar iaERK2 and 15N,1H-HSQC spectral
analyses, dialyzed against PBS pH 7.4, 5 mM EDTA, and
added 0.5 mM DSS, 2 mM DTT, 10 % (v/v) 99.96 %
D2O prior to recording. Chemical shift perturbations of
hNHE1cdt WT by variation of pH were determined
using 0.1 mM 15N-labeled hNHE1cdt WT in PBS, 2 mM
DTT, 0.5 mM DSS, 10 % (v/v) 99.96 % D2O at pH 7.2
and 7.4 and 15N,1H-HSQC spectral analyses. 15N trans-
verse relaxation times (R2) were determined using stand-
ard 15N,1H-HSQCs at a 750 MHz proton frequency field
at 5 °C with relaxation decays extracted from a nine-step
relaxation delay (0.01, 0.05, 0.09, 0.13, 0.17, 0.19, 0.21,
0.23, and 0.25 s). R2 values were calculated by fitting the
height of each peak to a single exponential decay func-
tion, and each fit was manually reviewed.
Native mass spectrometry
Protein samples were dialyzed against 200 mM ammo-
nium acetate supplemented with 0.5 mM DTT. To de-
tect the complex 12 μM ERK2 (MW 42343.7 Da) was
mixed with a 4 ×molar excess of NHE1cdt (48 μM,
14755.3 Da). Intact mass spectrometry experiments were
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performed on a Waters SYNAPT HDMS modified for
high mass transmission as previously described [78].
Gold-coated capillaries prepared in-house [79] were
filled with sample and held at 1.6 kV against a sample
cone of 200 V. Trap and transfer collision cells were
maintained at 10 V, with an argon collision gas at
6.6 × 10-2 mbar. Backing pressure in the early ion
optics was increased to 5.5 mbar to improve trans-
mission of high m/z ions. Spectra were assigned using
the UniDec software as previously described [46].
Model of hNHE1-ERK2 complex
The structure of iaERK2 in complex with PEA
[PDB:4IZ5] [18] was used for F-site recruitment site
modelling and the structure of iaERK2 in complex with
a MAP kinase interacting kinase peptide [PDB:4H3Q]
[80] for the D-recruitment site modelling. From the tem-
plates, the ERK2-NHE1 complex was modelled using
Modeler version 9.11 [81], generating an ensemble of
1,000 models. These were clustered using the Linkage al-
gorithm and the average structure from the most popu-
lated cluster selected as a final model. In the final
model, the remaining linker regions were analysed to as-
sess whether they were able to provide a structure of the
complex compatible with the hydrodynamic radius ob-
served experimentally. Since linker locations in the com-
plex were ambiguous, they are not shown in the figure.
In vitro ERK2 phosphorylation assays by NMR
Time course experiments were run at 25 °C. Assign-
ments were transferred to 25 °C by recording 15N,1H-
HSQCs at 5, 10, 15, 20, and 25 °C. NMR samples of
400 μL of 100 μM or 200 μM 15N-labeled hNHE1cdt or
variants were prepared in PBS buffer, 5 mM EDTA,
5 mM ATP, 15 mM MgCl2, 0.01 % (w/v) NaN3, 1 mM
PMSF, 0.5 mM DSS, 2 mM DTT, 10 % (v/v) 99.96 %
D2O, pH 7.0. A reference
15N,1H-HSQC spectrum was
recorded before addition of kinase. Phosphorylation was
started by addition of 10 μL of 0.1 mg/mL (55 nM,
401,000 units/mg) unlabeled active ERK2 (proteinkina-
se.de), resulting in a molar excess of hNHE1cdt:ERK2 of
1,800:1. Phosphorylation was monitored from extraction
of peak position and volumes from a series of 15N,1H-
HSQCs. Peak intensities were normalized to unper-
turbed residues (Q815). Kinetics of S693, S771, T779,
and S785 phosphorylation were extracted from non-
linear least squares fittings of disappearing peaks of the
unphosphorylated state and/or appearing peaks of the
phosphorylated state, as well as reporting neighbours to
single exponentials (S693 (D692, S693, and R700), S771
(S770, S771, and G773), T779 (V777 and T779), and
S785 (S785, S787, and S788)). Kinetics of S723 and S726
require fitting to bi-exponentials due to their crosstalk.
For this purpose peak intensities reporting on the
disappearing unphosphorylated state, the appearing
phosphorylated state, and both intermediates I1 and I2 of
both S723 and S726 were fitted. For the comparison of
the NHE1cdt variants, one peak was chosen for each site
and each variant, i.e. S693, S723, S771P, V777 (reporting
on T779), and S785. The disappearing peak of S723 re-
ports on both, S723 and S726 phosphorylation. Fully
phosphorylated 15N,13C-hNHE1cdt was assigned from
standard 3D triple resonance NMR experiments as
above.
Mammalian cell culture and transfections
AP-1 cells (a kind gift from Dr. S. Grinstein, University of
Toronto, ON, Canada), which are CHO-derived cells with
no endogenous NHE activity [41] and no recovery from
an acid load in the nominal absence of HCO3
- [41, 82],
were used for all experiments in mammalian cells. AP-1
cells were grown at 37 °C, 5 % CO2, 95 % humidity in α-
Minimum Essential Medium Eagle (Sigma) with 10 % fetal
bovine serum, 1 % L-glutamine, 1 % penicillin/strepto-
mycin (Gibco). Every 3–4 days, cells were passaged by
gentle trypsination, and only passages 5–35 were used for
experiments. WT and variant hNHE1 were expressed in
AP-1 cells as in [82]. Transfectants were selected for re-
sistance to 600 μg/ml G418 (Calbiochem), individual
clones picked, and hNHE1 expression verified by im-
munoblotting and immunofluorescence analysis.
EGF-mediated stimulation of ERK1/2 activity in AP-1 cells
Untransfected AP-1 cells or AP-1 cells expressing WT
or variant hNHE1 were grown to ~ 80 % confluence in
10 cm Petri dishes, and incubated for 15 min in absence
or presence of 100 ng/ml recombinant human EGF
(Sigma). Cells were subsequently lysed and processed for
immunoblotting as described below.
Immunoblotting
Immunoblotting was carried out essentially as in [26].
Antibody descriptions and experimental details are pro-
vided in Additional file 8. For quantifications, blots were
scanned, and band intensities quantified using Un-Scan-
IT Graph Digitizer software (Silk Scientific). The
pERK1/2 and ERK1/2 bands were normalized to those
of the loading control (tubulin) from the same gel to
eliminate gel-to-gel differences, and subsequently,
pERK1/2 was taken relative to total ERK1/2 from the
same experiment.
Immunofluorescence analysis
Immunofluorescence analysis was carried out essentially
as in [22]. Antibody descriptions and experimental de-
tails are provided in Additional file 8. Line scan quantifi-
cation of immunofluorescence was performed using
Olympus image analysis software, as the average pixel
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intensity at each wavelength across the line indicated.
Co-localization was quantified as the percentage of cells
with NHE1-ERK1/2 co-localization in both membranes,
based on representative immunofluorescence images.
Data are shown as mean percentage with SEM error
bars, based on analysis of at least 60 cells in three to five
independent replicates per condition.
Proximity ligation assay
Proximity ligation assay was carried out with the Duo-
link II Detection Reagents Red kit from Sigma Aldrich.
AP-1 WT cells were seeded on coverslips the day before
assaying. Cells were washed in ice-cold PBS, fixed in 4 %
PFA for 20 min on ice, and washed in Duolink II Buffer
A. Quenching was carried out in 0.1 M glycine for
15 min followed by permeabilization in 0.5 % Triton X-
100. After permeabilization, cells were washed in Duo-
link II Buffer A and added O-link blocking solution for
30 min. Incubation with primary antibodies for 60 min
in a humidity chamber at 37 °C was followed by 60 min
incubation with PLA probes diluted 1:5 in Duolink II
Antibody Diluent buffer at 37 °C. Coverslips were
washed in Duolink II Buffer A and added ligation solu-
tion diluted 1:5 for 30 min at 37 °C, followed by wash in
Duolink II Buffer A. Amplification solution diluted 1:5
was carried out for 100 min at 37 °C. After amplification,
coverslips were washed in Duolink Buffer A, incubated
with phalloidin488 for 1 h, and treated with DAPI to
stain nuclei. Finally, coverslips were washed in Duolink
Buffer A, mounted on object glass with mounting buffer,
and sealed with nail polish. Imaging was carried out with
an Olympus BX-61 epifluorescence microscope using
cellSens Dimensions V1.6 software. Images were taken
as z-stacks and z-projection images were created. Fur-
ther image processing and quantification were carried
out in ImageJ.
Data analysis and statistics
Data from mammalian cell culture on NHE1 function,
immunofluorescence, and immunoblotting are shown as
individual experiments representative of at least n = 3, or
as means ± standard error of the mean (SEM) as indi-
cated. ANOVA with Tukey post-test, or Student’s t-test,
as appropriate, were used to test for statistically signifi-
cant differences, with p < 0.05 as the significance level.
Availability of data and materials
Data supporting the results of this article are available
in the Additional files 1, 2, 3, 4, 5, 6, 7, and 9, and
further details on the materials and methods can be
found in Additional file 8. Backbone assignments of
the NHE1cdt have been deposited in the BioMagResBank
[BMRB:26755].
Additional files
Additional file 1: Figure S1. pH effect on chemical shifts of the hNHE1cdt
and ERK2 autoactivation and dephosphorylation by HePTP. (a) Variation of
amide chemical shift by a pH difference of 0.2 units for hNHE1cdt. (b) Native
PAGE of recombinantly expressed ERK2 reveals < 20 % auto-phosphorylation
that is removed upon addition of HePTP. (PDF 1208 kb)
Additional file 2: Figure S2. In vitro hNHE1cdt-ERK2 interaction. (a–b)
Combined chemical shift perturbations Δδ(15N,1H) and peak intensity
ratios of WT hNHE1cdt by interaction with ERK2 fully dephosphorylated
by HePTP. (c) Combined chemical shift perturbations Δδ(15N,1H) of
hNHE1cdt D3-AXA by iaERK2. (d–e) Combined chemical shift perturbations
Δδ(15N,1H) and peak intensity ratios of hNHE1cdt D1D2-(AXA)2 by iaERK2.
(f–g) Combined chemical shift perturbations Δδ(15N,1H) of hNHE1cdt F1-A
and F2-AA by iaERK2. (h) Internally urea referenced secondary chemical
shifts (ΔδC’) of hNHE1cdt WT. (PDF 399 kb)
Additional file 3: Figure S3. Analysis of the hNHE1cdt-iaERK2 complex
by size exclusion chromatography and circular dichroism (CD). (a) Size
exclusion chromatography profiles of the hNHE1cdt WT (blue), iaERK2
(black), and a mixture of both (red). Subtraction of the individual runs
from the mixture identifies a broad underlying peak with elution
properties of the complex (grey). (b) Zoom from panel (a). Fractions taken
for SDS-PAGE analysis (see panel (c)) are indicated by grey bars. (c)
Coomassie-stained SDS-PAGE of fractions from individual runs, as
indicated in panel (b). (d) Mean residual ellipticity CD spectra of
hNHE1cdt WT, iaERK2, and mixture reveal no significant gain of secondary
structure upon complex formation. (PDF 5632 kb)
Additional file 4: Figure S4. Affinity of the hNHE1cdt to iaERK2. (a)
Peak behaviour for residues of the D3-domain, the F1-site, and the F2-site
upon titration with iaERK2. Q815 is shown as a negative example. (b)
Plotted peak intensity changes (top) and chemical shifts (bottom) for
residues of the D3-domain, the F1-site, and the F2-site upon titration with
iaERK2. The D3-domain has the highest apparent affinity, and single
residue non-linear least squares fittings reveals a Kd
app of 35 ± 13 μM, 11 ±
2 μM, and 8 ± 1 μM for L684, T685, and V686, respectively. Global fitting
results in a Kd
app of 16 ± 2 μM for the hNHE1 D3-domain. The affinities for
the F1- and the F2-sites are lower (>50 μM). (PDF 304 kb)
Additional file 5: Figure S5. Effect of mutations on phosphorylation
kinetics. (a) Position of docking domains in the NHE1cdt relative to
phosphorylation sites. (b) Effect of primary phosphosite mutations (S693A
and T779A) on NHE1cdt phosphorylation kinetics by aERK2. Mutation on
either site leads to increased rates at the other site potentially due to the
absence of one sixth of high affinity phosphosites (intramolecular
competition). Interestingly, the absence of T779 phosphorylation leads to
slower rates at S771 and S785, which are close enough to sense the status of
T779. (c) Effect of D-domain and F-site mutations on NHE1cdt phosphorylation
kinetics by aERK2. The order of phosphorylation events is the same for all
variants, yet the rates are modulated by the mutations. (PDF 468 kb)
Additional file 6: Figure S6. NHE1 co-localizes with ERK2. (a) Immuno-
fluorescence images of AP-1 cells (hNHE1 D1D2-(AXA)2 and D1D2D3-(AXA)3)
treated or not for 15 min with EGF (100 ng/ml). Merged images were zoomed
to highlight the co-localization of ERK1/2 and NHE1 (white arrows). All other
variants are shown in Figure 5. Data are representative of three independent
biological replicates. (b) Representative line scans across membrane areas of
images as in (a). (PDF 2105 kb)
Additional file 7: Figure S7. Disorder prediction for Tpr and nuclear
pore proteins. (a–d) Intrinsic disorder was predicted by PONDR-FIT and
DISOPRED 3.1 for (a) Tpr, (b) Nup50, (c) Nup153, and (d) Nup214, and the
positions of FXF repeats were indicated by X. Notably, the great majority
of FXF repeats localize to predicted disordered regions. (PDF 353 kb)
Additional file 8: Supplementary materials and methods. (DOCX 25 kb)
Additional file 9: Figure S8. Purity of protein preparations. (a)
Coomassie-stained SDS-PAGE (Bio-Rad) of hNHE1cdt WT, variants, and
iaERK2. A low molecular weight marker (LMW) was used as standard (GE
Healthcare). (b) Phosphorylation of the hNHE1cdt variants by aERK2 leads
to an upward shift on SDS-PAGE towards apparent higher molecular
weight relative to the unphosphorylated state. (PDF 1194 kb)
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